Correlation between Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a Chinese Han population

National Medical Journal of China

Volumn 93, Issue 3, 2013, Pages 182-186

  Wang, Jing Tao ^a   Li, Ling ^a   Yuan, Jing ^a   Zhang, Zhen Xin ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Age at onset; Alzheimer's disease; Apolipoprotein E; Gene polymorphism

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; CHINESE; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; FAMILY HISTORY; GENETIC ANALYSIS; GENOTYPE; HUMAN; LINKAGE ANALYSIS; MEMORY DISORDER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84874290992     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.03.007     Document Type: Article

References (19)

1. Corder E H, Saunders A M, Strittmatter W J, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 1993, 261:921-923.
2. Raber J, Huang Y, Ashford J W. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging, 2004, 25:641-650.
3. Farrer L A, Cupples L A, Haines J L, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 1997, 278: 1349-1356.
4. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 1984, 34:939-944.
5. Dubois B, Feldman H H, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol, 2007, 6:734-746.
6. 2008, 41:835-839.
7. Hixson J E, Vernier D T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res, 1990, 31:545-548.
8. van der Flier W M, Pijnenburg Y A, Fox N C, et al. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ε4 allele. Lancet Neurol, 2011, 10:280-288.
9. Munoz D G, Feldman H. Causes of Alzheimer's disease. CMAJ, 2000, 162:65-72.
10. Davidson Y, Gibbons L, Pritchard A, et al. Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease. Dement Geriatr Cogn Disord, 2007, 23:60-66.
11. Sando S B, Melquist S, Cannon A, et al. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease: a case control study from central Norway. BMC Neurol, 2008, 8:9.
12. Lehtovirta M, Helisalmi S, Mannermaa A, et al. Apolipoprotein E polymorphism and Alzheimer's disease in eastern Finland. Neurosci Lett, 1995, 185:13-15.
13. Balasa M, Gelpi E, Antonell A, et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology, 2011, 76:1720-1725.
14. 2009, 17:261-266.
15. Shimada K, Yasuda M, Maeda K. Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease. Seishin Shinkeigaku Zasshi, 1997, 99:575-587.
16. Raygani A V, Zahrai M, Raygani A V, et al. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett, 2005, 375:1-6.
17. Silverman J M, Smith C J, Marin D B, et al. Familial patterns of risk in very late-onset Alzheimer disease. Arch Gen Psychiatry, 2003, 60:190-197.
18. Romas S N, Santana V, Williamson J, et al. Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE. Arch Neurol, 2002, 59:87-91.
19. Olarte L, Schupf N, Lee J H, et al. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics. Arch Neurol, 2006, 63:1586-1590.